Cite
HARVARD Citation
Harasfflma, S. et al. (n.d.). Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in subjects with type 2 diabetes (SUSTAIN 1). Diabetes research and clinical practice. pp. S121-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Harasfflma, S. et al. (n.d.). Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in subjects with type 2 diabetes (SUSTAIN 1). Diabetes research and clinical practice. pp. S121-. [Online].